Loading term…
Phase of the product lifecycle after approval. Includes post-marketing surveillance, PSURs, RMP updates, variations, and compliance with conditions of the marketing authorisation.
After approval, the MAH must fulfil post-marketing commitments, report adverse events, and submit variations for changes.
GVP, 21 CFR 314.80, Directive 2001/83/EC
Treating approval as the end of regulatory obligations. Missing commitments or variation deadlines.
What post-marketing commitments do you have and how do you track and complete them?